News in the Life Sciences Industry

ABBOTT PARK, Ill., July 6, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's next-generation Gallant(TM) implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices.... Read more ››

KING OF PRUSSIA, Pa., July 6, 2020 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that the first patient has... Read more ››

TOKYO, July 6, 2020 /PRNewswire/ -- HOYA Corporation (TSE:7741, "HOYA") and Hitachi, Ltd. (TSE:6501, "Hitachi") today announced a five year contract regarding Endoscopic Ultrasound Systems [EUS] by which, i) the parties will strengthen technical collaboration, and ii) Hitachi will continue supplying... Read more ››

European Medicines Agency Approves 21-Day Dosing Intervals for Adult Haemophilia B Patients

HOUSTON, July 1, 2020 /PRNewswire/ -- FibroGenesis announced today identification of molecular mechanisms associated with the potent reduction of lung inflammation previously reported by the Company in an animal model of COVID-19 lung failure.

LONDON, July 1, 2020 /PRNewswire/ -- Polygon Global Partners LLP acts as investment manager to funds and accounts that hold a total of 859,610 ordinary shares and 1,750,000 preferred shares of Biotest AG, representing approximately 6.59% of the share capital of the company.

SEOUL, Korea, June 30, 2020 /PRNewswire/ -- Janssen Korea Ltd. and Johnson & Johnson Innovation LLC today announced the launch of the Seoul Innovation QuickFire Challenge for Healthcare in the New Normal in collaboration with the Seoul Metropolitan Government (SMG) and the... Read more ››

- QuickFire Challenge calls on innovators to identify and accelerate potential solutions aiming to improve patient care in our post-COVID world.

Expansion will help meet the growing demand for plasmid DNA offerings